Pursuant to Regulations 74(5) of SEBI (DP) Regulations, 2018, please find enclosed herewith certificate received from KFIN Technologies Limited, Registrar & Share Transfer Agent of the ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Mahamaya Lifesciences Ltd has submitted a compliance certificate for Q4 FY2025-26 (January-March 2026) confirming that Regulation 74(5) of SEBI (Depositories and Participants) Regulations is not applicable to the company. The certificate from Registrar and Share Transfer Agent KFIN Technologies Limited confirms that the entire shareholding of the company is already in dematerialized (demat) form. No requests for re-materialization were received from shareholders during the quarter. This is a routine regulatory filing demonstrating the company's compliance with SEBI's dematerialization requirements.
This filing has no direct impact on the stock price or shareholder value. It simply confirms that the company's shares are fully dematerialized with no pending demat/remat requests, indicating clean shareholding documentation.